A phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).

被引：0
|
作者：
Sabichi, A. L. [1 ]
Kies, M. S. [1 ]
Glisson, B. S. [1 ]
Lu, C. [1 ]
Ginsberg, L. E. [1 ]
Bartos, C. I. [1 ]
Feng, L. [1 ]
Tran, H. T. [1 ]
Lippman, S. M. [1 ]
Blumenschein, G. R., Jr. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5532
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase Ib/II study of the PI3Kα inhibitor BYL719 in combination with cetuximab in recurrent/metastatic squamous cell cancer of the head and neck (SCCHN)
    Razak, Albiruni R. A.
    Ahn, Myung-Ju
    Yen, Chia-Jui
    Solomon, Benjamin J.
    Lee, Se-Hoon
    Wang, Hung-Ming
    Munster, Pamela N.
    L-Van Herpen, Carla M.
    Gilbert, Jill
    Pal, Rupam Ranjan
    Blumenstein, Lars
    Gomez-Carrillo, Belen
    Coughlin, Christina Marie
    Lim, Wan-Teck
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Phase I study of gefitinib plus celecoxib in patients with metastatic and/or locally recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Wirth, LJ
    Haddad, RI
    Wieczorek, TJ
    Faucher, JL
    Clark, JR
    Norris, CM
    Posner, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 498S - 498S
  • [43] Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
    Vermorken, J. B.
    Licitra, L.
    Stoehlmacher-Williams, J.
    Dietz, A.
    Lopez-Picazo, J. M.
    Hamid, O.
    Hossain, A. M.
    Chang, S. -C.
    Gauler, T. C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (13) : 2877 - 2883
  • [44] Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC).
    Kim, E. S.
    Kies, M. S.
    Glisson, B. S.
    Ginsberg, L. E.
    Holsinger, F. C.
    Burke, B. J.
    Truong, M.
    Tsao, A. S.
    Hong, W. K.
    Lippman, S. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 285S - 285S
  • [45] Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (NNSCC).
    Kim, ES
    Kies, M
    Sabichi, A
    Ginsberg, L
    Burke, B
    Holsinger, C
    Feng, L
    Truong, MT
    Glisson, B
    Hong, WK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 511S - 511S
  • [46] Results of a phase II study evaluating monalizumab in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
    Fayette, J.
    Lefebvre, G.
    Posner, M. R.
    Bauman, J.
    Salas, S.
    Even, C.
    Saada-Bouzid, E.
    Seiwert, T.
    Colevas, D.
    Calmels, F.
    Zerbib, R.
    Chammard, A. Boyer
    Cohen, R.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 374 - 374
  • [47] Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study
    Schena, M
    Barone, C
    Birocco, N
    Dongiovanni, D
    Numico, G
    Colantonio, I
    Bertetto, O
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (03) : 271 - 276
  • [48] Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma
    Adamo, V
    Ferraro, G
    Pergolizzi, S
    Sergi, C
    Laudani, A
    Settineri, N
    Alafaci, E
    Scimone, A
    Spano, F
    Spitaleri, G
    [J]. ORAL ONCOLOGY, 2004, 40 (05) : 525 - 531
  • [49] Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study
    M. Schena
    C. Barone
    N. Birocco
    D. Dongiovanni
    G. Numico
    I. Colantonio
    O. Bertetto
    [J]. Cancer Chemotherapy and Pharmacology, 2005, 55 : 271 - 276
  • [50] A phase I/II study of oncolytic reovirus plus chemotherapy (carboplatin/paclitaxel) in patients with advanced solid tumors (with emphasis on patients with squamous cell carcinoma of the head and neck (SCCHN)
    Harrington, Kevin J.
    Karapanagiotou, Eleni M.
    Hardev, Pandha
    Nutting, Christopher M.
    Gore, Martin
    Karl, Mettinger
    Geoff, Hall
    Melcher, Alan
    Mercel, Ball
    Coffey, Matt
    Thompson, Brad
    Chester, John
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
12345